Short news for quality minds. Power your niche.

Govt introduces bill to bar state levies on mining, enhance investor interest

Govt introduces bill to bar state levies on mining, enhance investor interest

mint

The government introduced the Mines and Minerals (Development and Regulation) Amendment Bill, 2026 in the Lok Sabha on Monday. It bars states from imposing taxes on mining to reduce financial burdens. The government said, "excessive fiscal burden makes mining operations commercially unviable," and hopes this move will boost investor interest.

Tap to Read More
Ethanol-blended diesel fails safety tests, Centre rules out wider rollout for now

Ethanol-blended diesel fails safety tests, Centre rules out wider rollout for now

The Telegraph

Ethanol-blended diesel failed safety tests, leading the Centre to rule out a wider rollout for now. Minister Suresh Gopi said on Monday that the fuel’s flash point fell sharply during scientific evaluations. The government currently focuses its blending programme on petrol, aiming for a 20 per cent target instead.

Tap to Read More
Indian Hotels targets 25% growth from culinary platform Qmin

Indian Hotels targets 25% growth from culinary platform Qmin

Business Line

Indian Hotels Company Ltd expects 25 per cent growth from its culinary platform Qmin this financial year. Aided by a tie-up with the Tata group's BigBasket, Qmin delivered over two lakh orders in FY25 alone. The company now plans to expand its food outlets at airports and Ginger hotel locations.

Tap to Read More
Ethanol, EVs must coexist in India's clean mobility transition; E20 mileage impact limited: IFGE

Ethanol, EVs must coexist in India's clean mobility transition; E20 mileage impact limited: IFGE

Economic Times

The Indian Federation of Green Energy said ethanol and electric vehicles must coexist for India’s clean mobility transition. Dilip Patil said, "The debate should not be framed as ethanol versus EVs India needs both." Studies showed E20 fuel causes a small drop in mileage, but it helps reduce oil imports.

Tap to Read More
Hitachi Energy India: Grid expansion, not generation, emerges as the next bottleneck

Hitachi Energy India: Grid expansion, not generation, emerges as the next bottleneck

Business Line

Hitachi Energy India reached a record order book of ₹32,000 crore as demand for grid infrastructure grows. MD and CEO N Venu said, "Shifting from project-by-project procurement to a programme-based approach could provide greater visibility." Transmission, renewables, and data centres drive this surge, helping the company plan for future capacity.

Tap to Read More
Fusion Finance turns corner, logs ₹62 crore profit

Fusion Finance turns corner, logs ₹62 crore profit

Business Line

Fusion Finance reported a net profit of ₹62 crore in the June quarter, compared to a ₹92 crore loss last year. Loan disbursements jumped 88 per cent to ₹1,783 crore. MD Sanjay Garyali said the improvement “validates the disciplined approach to underwriting, risk management and execution” for the company.

Tap to Read More
Milky Mist raises over Rs 465 crore via anchor book ahead of Rs 1,553-crore IPO; Temasek buys more shares

Milky Mist raises over Rs 465 crore via anchor book ahead of Rs 1,553-crore IPO; Temasek buys more shares

Moneycontrol

Milky Mist Dairy Food raised Rs 465.3 crore from 19 anchor investors on August 10 ahead of its Rs 1,553-crore IPO. The Chennai-based firm finalised the allocation of 3.32 crore shares at the upper price band. Temasek Holdings got the largest share, while many domestic mutual funds also bought in.

Tap to Read More
SEBI confirms restrictions on Nirman Agri Genetics, rejects bid to resume corporate actions

SEBI confirms restrictions on Nirman Agri Genetics, rejects bid to resume corporate actions

Moneycontrol

SEBI on Monday confirmed restrictions on Nirman Agri Genetics and its managing director Pranav Kailas Bagal. The regulator rejected their bid to resume corporate actions, citing concerns over diverted IPO funds. SEBI noted, “financial profits reported on the basis of mis-stated or manipulated accounting entries cannot form a legitimate basis.”

Tap to Read More
ifty 50 may deliver 14-17% return in FY27 as earnings rebound: Birla MF

ifty 50 may deliver 14-17% return in FY27 as earnings rebound: Birla MF

Business Line

Aditya Birla Sun Life AMC expects the Nifty to deliver a 14 to 17 per cent return in FY27. Harish Krishnan said, "earnings of the top 1,000 listed companies are expected to rise 11 per cent in FY27." Corporate earnings got a boost from consumption, though market valuations remain in the expensive zone.

Tap to Read More
Aretto targets 100 retail touchpoints as India kids’ footwear brand plots global expansion

Aretto targets 100 retail touchpoints as India kids’ footwear brand plots global expansion

The Economic Times

Aretto targets more than 100 retail touchpoints by fiscal 2027 as the Indian kids’ footwear brand expands globally. The company is shifting to an omnichannel model to reduce reliance on paid social media. Founder Satyajit Mittal said, “Aretto's retail rollout is the clearest signal of where we're headed.”

Tap to Read More
Nippon India Equity buys stake in Iris Clothings that has risen 250% in five years

Nippon India Equity buys stake in Iris Clothings that has risen 250% in five years

Livemint

Nippon India Equity Opportunities AIF bought 15 lakh shares of Iris Clothings at ₹55 each. The stock hit a record high of ₹56.25 on Tuesday. Shares started recovering in March 2025 and gained 235% since then. Many investors track these bulk deals as the company continues its strong market run.

Tap to Read More
Wockhardt eyes US launch of Zaynich in first quarter 2027; Europe approval expected by year-end, says Habil Khorakiwala

Wockhardt eyes US launch of Zaynich in first quarter 2027; Europe approval expected by year-end, says Habil Khorakiwala

Moneycontrol

Wockhardt plans to launch its antibiotic Zaynich in the US by the first quarter of 2027. Founder Habil Khorakiwala said on Monday that the firm expects European approval by early 2027. "Zaynich will be primarily driven by the knowledge and scientific aspect of the new drug," he added during the event.

Tap to Read More